Antimicrobial consumption and resistance in bacteria from humans and animals

  01 July 2021

This report was produced as a collaboration between the European Centre for Disease Prevention and Control (ECDC), the European Food Safety Authority (EFSA) and the European Medicines Agency (EMA). It is the third joint inter-agency report on integrated analysis of antimicrobial agent consumption and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals (JIACRA), prepared by the three agencies at the request of the European Commission (EC). Antimicrobial resistance (AMR) constitutes a significant public health problem in Europe as well as in other parts of the world, representing a serious social and economic burden and a threat to animal health and production. The main driver behind AMR is antimicrobial consumption (AMC), in both humans and food-producing animals. Recognising that human and animal health are interconnected, this report is based on a ‘One-Health’ approach. 

This report provides an integrated analysis of possible relationships between AMC in humans and food-producing animals and the occurrence of AMR in bacteria from humans and food-producing animals.

Further reading: ECDC, EFSA, EMA
Author(s): ECDC, EFSA, EMA
Healthy Animals   Healthy Patients   Secure Foods  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!